| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Elnaz Amini, Taha Shokrnejad-Namin, Mohammad-Reza Zarrindast, Fatemeh Khakpa. Synergistic effect between citalopram and muscimol upon induction of anxiolytic- and antidepressant-like effects in male mice: An isobologram analysis. IBRO neuroscience reports. vol 16. 2024-02-28. PMID:38415182. |
there is evidence that both the gabaergic system and serotonin reuptake inhibitor (ssri) such as citalopram are involved in the modulation of anxiety and depression processes. |
2024-02-28 |
2024-03-01 |
mouse |
| Sara Rogers, Patrick J Silva, George Udeani, Monica Deleon, Sriarchala Mutyala, Ladan Panahi, Asim Abu-Baker, Gabriel Neal, Kenneth S Ramo. Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation. Drugs in R&D. 2024-02-27. PMID:38413481. |
selective serotonin reuptake inhibitors (ssri) are commonly used for the treatment of depression and anxiety. |
2024-02-27 |
2024-03-01 |
Not clear |
| Yi Zhao, Yuzhou Zhang, Lin Yang, Kanghuai Zhang, Sha L. Safety Profile of Selective Serotonin Reuptake Inhibitors in Real-World Settings: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System. The Annals of pharmacotherapy. 2024-02-26. PMID:38407147. |
selective serotonin reuptake inhibitors (ssris) are the most frequently prescribed agents to treat depression. |
2024-02-26 |
2024-02-28 |
Not clear |
| Xin-Jue Shan, Dan Kang, Zhe Chen, Shi-Yu Zhang, Chun-Xiang Li. [Systematic review and Meta-analysis of efficacy and safety of Shumian Capsules in treatment of insomnia]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. vol 49. issue 1. 2024-02-25. PMID:38403359. |
in addition, shumian capsules had an advantage in treating insomnia complicated with depression in terms of hamd score(p<0.000 1) and reducing the serum levels of 5-ht, tsh, t3, and t4 in insomnia patients(p<0.05). |
2024-02-25 |
2024-02-28 |
Not clear |
| Michael Frazure, In Morimoto, Nathan Fielder, Nicholas Mellen, Kimberly Iceman, Teresa Pitt. Serotonin therapies for opioid-induced disordered swallow and respiratory depression. Journal of applied physiology (Bethesda, Md. : 1985). 2024-02-22. PMID:38385184. |
serotonin therapies for opioid-induced disordered swallow and respiratory depression. |
2024-02-22 |
2024-02-24 |
rat |
| Darya Rostam Ahme. Letter to the editor concerning: "The serotonin theory of depression: a systematic umbrella review of the evidence". Molecular psychiatry. 2024-02-20. PMID:38374358. |
letter to the editor concerning: "the serotonin theory of depression: a systematic umbrella review of the evidence". |
2024-02-20 |
2024-02-22 |
Not clear |
| Danilo Arnone, Toby Wise, Paul B Fitzgerald, Catherine J Harme. The involvement of serotonin in major depression: nescience in disguise? Molecular psychiatry. 2024-02-20. PMID:38374356. |
the involvement of serotonin in major depression: nescience in disguise? |
2024-02-20 |
2024-02-22 |
Not clear |
| Konstantinos N Fountoulakis, Eva Maria Tsapaki. Neither serotonin disorder is at the core of depression nor dopamine at the core of schizophrenia; still these are biologically based mental disorders. Molecular psychiatry. 2024-02-20. PMID:38374355. |
neither serotonin disorder is at the core of depression nor dopamine at the core of schizophrenia; still these are biologically based mental disorders. |
2024-02-20 |
2024-02-22 |
Not clear |
| Andrew L Smith, Andre F Carvalho, Marco Solm. Methodological concerns in umbrella review of serotonin and depression. Molecular psychiatry. 2024-02-20. PMID:38374357. |
methodological concerns in umbrella review of serotonin and depression. |
2024-02-20 |
2024-02-22 |
Not clear |
| Diksha Choudhary, Bhupinder Kumar, Rajwinder Kau. Nitrogen-containing heterocyclic compounds: A ray of hope in depression? Chemical biology & drug design. vol 103. issue 2. 2024-02-16. PMID:38361139. |
drugs that are currently being used for the management of various types of depression include selective serotonin reuptake inhibitors, tricyclic antidepressants, atypical antidepressants, serotonin, noradrenaline reuptake inhibitors, etc. |
2024-02-16 |
2024-02-18 |
Not clear |
| Kazi Ishtiak-Ahmed, Christopher Rohde, Christian Otte, Christiane Gasse, Ole Köhler-Forsber. Comparative effectiveness of selective serotonin reuptake inhibitors (SSRIs) for depression in 43,061 older adults with chronic somatic diseases: A Danish target trial emulation study. General hospital psychiatry. vol 87. 2024-02-14. PMID:38354442. |
comparative effectiveness of selective serotonin reuptake inhibitors (ssris) for depression in 43,061 older adults with chronic somatic diseases: a danish target trial emulation study. |
2024-02-14 |
2024-02-17 |
Not clear |
| Kazi Ishtiak-Ahmed, Christopher Rohde, Christian Otte, Christiane Gasse, Ole Köhler-Forsber. Comparative effectiveness of selective serotonin reuptake inhibitors (SSRIs) for depression in 43,061 older adults with chronic somatic diseases: A Danish target trial emulation study. General hospital psychiatry. vol 87. 2024-02-14. PMID:38354442. |
to investigate the comparative effectiveness of commonly used selective serotonin reuptake inhibitors (ssris) for comorbid depression in older adults with chronic somatic diseases by applying a target-trial-emulation framework. |
2024-02-14 |
2024-02-17 |
Not clear |
| Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M Peill, Leor Roseman, David J Nutt, David Erritzoe, Robin Carhart-Harris, Bruna Giribald. Psychedelics and sexual functioning: a mixed-methods study. Scientific reports. vol 14. issue 1. 2024-02-07. PMID:38326446. |
it is also a common side effect of selective serotonin reuptake inhibitors (ssris), a first line treatment for depression. |
2024-02-07 |
2024-02-10 |
human |
| Yi Li, Yan Yin, Yingyi Yu, Xiwen Hu, XiaoYan Liu, Sha W. The potential predictors for treatment-resistance depression after selective serotonin reuptake inhibitors therapy in Han Chinese: A resting-state functional magnetic resonance imaging study. Early intervention in psychiatry. 2024-02-06. PMID:38320861. |
the potential predictors for treatment-resistance depression after selective serotonin reuptake inhibitors therapy in han chinese: a resting-state functional magnetic resonance imaging study. |
2024-02-06 |
2024-02-09 |
Not clear |
| Konstantinos N Fountoulakis, Mauricio Tohen, Carlos A Zarat. Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 81. 2024-02-04. PMID:38310714. |
the original model suggests that a constellation of effects on different receptors is necessary, but refinements, including the present study, suggest that the inhibition of the serotonin reuptake at the first level, the 5ht-2a blockade at the second level, and the norepinephrine alpha-1 receptors blockade at a third level in combination with d1 blockade contribute to the antidepressant effect in acute bipolar depression. |
2024-02-04 |
2024-02-07 |
Not clear |
| Sandra Ledesma-Corvi, Jordi Jornet-Plaza, Laura Gálvez-Melero, M Julia García-Fuste. Novel rapid treatment options for adolescent depression. Pharmacological research. 2024-02-03. PMID:38309382. |
there is an urgent need for novel fast-acting antidepressants for adolescent treatment-resistant depression and/or suicidal risk, since the selective serotonin reuptake inhibitors that are clinically approved for that age (i.e., fluoxetine or escitalopram) take weeks to work. |
2024-02-03 |
2024-02-06 |
Not clear |
| Sebastián García Menéndez, Walter Manuch. Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health. Current pharmaceutical design. 2024-02-02. PMID:38303529. |
lastly, its role in intestinal microbiota and serotonin synthesis contributes to psychiatric disorders like schizophrenia and depression. |
2024-02-02 |
2024-02-04 |
Not clear |
| Kelly E Dunham, B Jill Vento. Electrochemical and biosensor techniques to monitor neurotransmitter changes with depression. Analytical and bioanalytical chemistry. 2024-01-30. PMID:38289354. |
three neurotransmitters: serotonin, histamine, and glutamate, have been proposed to be key mediators of depression. |
2024-01-30 |
2024-02-01 |
Not clear |
| Elizabeth Lovegrove, Alice Maidwell-Smith, Beth Stuart, Miriam Sante. SSRIs in women of reproductive age; a systematic review of local formularies. BJGP open. 2024-01-25. PMID:38272494. |
depression is the second most common chronic condition affecting women of reproductive age; 23.4% of women enter pregnancy with depression and use of selective serotonin reuptake inhibitors (ssris) in pregnancy is often necessary for maternal wellbeing. |
2024-01-25 |
2024-01-28 |
Not clear |
| Stefano Comai, Nicolas Nunez, Tobias Atkin, Maykel F Ghabrash, Rita Zakarian, Allan Fielding, Marie Saint-Laurent, Nancy Low, Garrett Sauber, Eugenio Ragazzi, Cecilia J Hillard, Gabriella Gobb. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms. BMC medicine. vol 22. issue 1. 2024-01-25. PMID:38273283. |
the endocannabinoid (ecb) system and the serotonin (5-ht) are both implicated in the severity of the depression. |
2024-01-25 |
2024-01-28 |
Not clear |